Gsa Capital Partners LLP United Therapeutics Corp Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$214.88 - $256.94 $138,812 - $165,983	646 Added 53.04%	1,864 $409,000
Q3 2023 Nov 15, 2023	BUY	$211.82 - $248.24 $257,996 - $302,356	1,218 New	1,218 $275,000
Q2 2022 Aug 09, 2022	SELL	$174.81 - $241.14 $323,573 - $446,350	-1,851 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$166.16 - $213.96 $307,562 - $396,039	1,851 New	1,851 $332,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $657,100 - $770,325	-3,565 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $641,200 - $766,047	3,565 New	3,565 $658,000
Q4 2020 Feb 03, 2021	SELL	$101.87 - $151.79 $1.1 Million - $1.64 Million	-10,799 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$99.9 - $121.13 $1.08 Million - $1.31 Million	10,799 New	10,799 $1.09 Million
Q2 2020 Aug 11, 2020	SELL	$92.74 - $125.82 $666,800 - $904,645	-7,190 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$79.39 - $115.35 $379,960 - $552,065	4,786 Added 199.08%	7,190 $682,000
Q4 2019 Feb 12, 2020	SELL	$78.31 - $95.34 $374,165 - $455,534	-4,778 Reduced 66.53%	2,404 $212,000
Q3 2019 Nov 12, 2019	SELL	$74.85 - $85.99 $372,977 - $428,488	-4,983 Reduced 40.96%	7,182 $573,000
Q2 2019 Aug 06, 2019	SELL	$76.06 - $120.81 $322,190 - $511,751	-4,236 Reduced 25.83%	12,165 $950,000
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $593,932 - $703,074	5,543 Added 51.05%	16,401 $1.93 Million
Q4 2018 Feb 12, 2019	BUY	$101.4 - $128.73 $785,038 - $996,627	7,742 Added 248.46%	10,858 $1.18 Million
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $127,581 - $145,124	-1,121 Reduced 26.46%	3,116 $398,000
Q2 2018 Aug 09, 2018	SELL	$101.14 - $118.31 $816,300 - $954,880	-8,071 Reduced 65.58%	4,237 $479,000
Q1 2018 May 11, 2018	SELL	$107.21 - $151.94 $1.09 Million - $1.55 Million	-10,181 Reduced 45.27%	12,308 $1.38 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $839,783 - $1.07 Million	7,082 Added 45.97%	22,489 $3.33 Million
Q3 2017 Nov 20, 2017	BUY	$114.6 - $136.81 $1.77 Million - $2.11 Million	15,407	15,407 $1.81 Million

Others Institutions Holding UTHR

# of Institutions

679

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.64 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.18 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.06 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$830 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account